Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
12/25/2007 | US7312030 Monitoring capability of genetically engineered arterivirus to propagate in cells; viricides; veterinary medicine; genetic vaccines |
12/25/2007 | US7311922 comprising antigens and excipients, which increse serological sensitivity of individuals infected with tuberculosis; for use in diagnosis and prevention of tuberculosis infection |
12/25/2007 | US7311921 Effective against FIVDix, FIVUK8, FIVBang, FIVAom1, FIVAom2, FIVPet, and FIVShi. |
12/25/2007 | US7311918 Generation of rotavirus subunit proteins for use in vaccines and methods of providing protective immunity to vertebrates, including humans, against rotavirus infection or disease; providing cell-mediated immune response |
12/25/2007 | US7311917 Membrane proteins; fusion proteins; vaccines; kits |
12/25/2007 | US7311915 peptide mixture; induce immunology response; gag protein; vaccines |
12/25/2007 | US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy |
12/21/2007 | WO2007147133A1 Stabilized tetracycline compositions |
12/21/2007 | WO2007147117A2 Methods of reducing or eliminating salmonella in reptiles and/or their eggs |
12/21/2007 | WO2007146039A2 Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide |
12/21/2007 | WO2007145689A1 Use of alpha-toxin for treating and preventing staphylococcus infections |
12/21/2007 | WO2007145191A1 Coated tablet |
12/21/2007 | WO2007144444A1 Active packaging that inhibits food pathogens |
12/21/2007 | WO2007143934A1 Pharmaceutical composition for the prophylaxis and treatment of hiv infection and its use |
12/21/2007 | WO2007143880A1 Compounds for preventing and treating bacterial infection and its preparation and use |
12/21/2007 | WO2007143858A1 Dph2 gene deletion mutant and uses thereof |
12/21/2007 | WO2007143851A1 Fermented plant extracts, methods of production and uses |
12/21/2007 | WO2007081288A9 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
12/21/2007 | WO2007081287A9 Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
12/21/2007 | WO2007064620A3 Compositions comprising a combination of ccr5 and cxcr4 antagonists |
12/21/2007 | WO2007038860A8 Odcase inhibitors as anti-virals and antibiotics |
12/21/2007 | WO2007033444A3 Antiviral therapy with carbohydrate binding agents |
12/21/2007 | WO2003064613A3 Amidases, nucleic acids encoding them and methods for making and using them |
12/21/2007 | CA2682755A1 Fermented plant extracts, methods of production and uses |
12/21/2007 | CA2655565A1 Dph2 gene deletion mutant and uses thereof |
12/21/2007 | CA2655133A1 Use of alpha-toxin for treating and preventing staphylococcus infections |
12/21/2007 | CA2654317A1 Single-chain multivalent binding proteins with effector function |
12/21/2007 | CA2654101A1 Active food pathogen inhibitor packaging |
12/20/2007 | US20070293585 Gossypol co-crytals and the use thereof |
12/20/2007 | US20070293564 Dimeric compounds and their use as anti-viral agents |
12/20/2007 | US20070293560 Compounds and compositions |
12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
12/20/2007 | US20070293517 Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety |
12/20/2007 | US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same |
12/20/2007 | US20070293493 Oxazolidinone antibiotics and derivatives thereof |
12/20/2007 | US20070293482 Process for Preparing Benzodiazepines |
12/20/2007 | US20070293478 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses |
12/20/2007 | US20070293472 Novel 14 and 15 Membered Ring Compounds |
12/20/2007 | US20070293469 Compositions and methods for the treatment and prevention of disease |
12/20/2007 | US20070293448 Synthetic gagpol genes and their uses |
12/20/2007 | US20070293444 Novel Nucleoside Transport Inhibitors |
12/20/2007 | US20070293424 Antitumoral and Antiviral Peptides |
12/20/2007 | US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
12/20/2007 | US20070293417 Polyamides for treating human papilloma virus |
12/20/2007 | US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease |
12/20/2007 | US20070292545 Anti-infective agents and methods of use |
12/20/2007 | US20070292499 Processes for the Preparation of Solid Dosage Forms of Amorphous Valganciclovir Hydrochloride |
12/20/2007 | US20070292494 Carbohydrate-Derivatized Liposomes for Targeting Cellular Carbohydrate Recognition Domains of Ctl/Ctld Lectins, and Intracellular Delivery of Therapeutically Active Compounds |
12/20/2007 | US20070292477 Association of Antimicrobial Compounds with Surfaces and Polymers |
12/20/2007 | US20070292461 Oleaginous pharmaceutical and cosmetic foam |
12/20/2007 | US20070292452 Vaccine Compositions Which Are Obtained From Streptomyces |
12/20/2007 | US20070292450 Immunogenic Compositions of Staphylococcus Epidermidis Polypeptide Antigens |
12/20/2007 | US20070292449 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
12/20/2007 | US20070292447 Peptide Minotopes of Mycobacterial Mannosylated Lipoglycans and Uses Thereof |
12/20/2007 | US20070292437 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof |
12/20/2007 | US20070292435 Polypeptide for use in the treatment of tumors, autoimmune, inflammatory and viral diseases; graft vs. host disease |
12/20/2007 | US20070292425 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof |
12/20/2007 | US20070292422 Using CD70 specific immunoglobulins to prevent and treat cell proliferative disorders; immunosuppressant |
12/20/2007 | US20070292413 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
12/20/2007 | US20070292404 Antimicrobial polymer conjugates |
12/20/2007 | US20070292390 Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies |
12/20/2007 | US20070292359 Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
12/20/2007 | US20070292355 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions |
12/19/2007 | EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use |
12/19/2007 | EP1867718A2 Therapeutically useful synthetic oligonucleotides |
12/19/2007 | EP1867658A1 Lactalbumin production process |
12/19/2007 | EP1867339A1 Anti-viral agent |
12/19/2007 | EP1867336A2 Adminstration of an anti-endotoxin drug by intravenous infusion |
12/19/2007 | EP1867332A1 Pharmaceutical composition and method using antifungal agent in combination |
12/19/2007 | EP1867329A2 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamides as therapeutic compounds |
12/19/2007 | EP1866339A2 Gitr binding molecules and uses therefor |
12/19/2007 | EP1866319A1 Phosphono-pent-2-en-1-yl nucleosides and analogs |
12/19/2007 | EP1866312A1 Cyclic iminopeptide derivatives |
12/19/2007 | EP1866306A1 Imidazopyridine derivatives useful as inos inhibitors |
12/19/2007 | EP1866291A1 Antibacterial amide macrocycles vi |
12/19/2007 | EP1866283A2 4-fluorophenyl-derivatives of 1-{[1,5 -bis (4-chlorophenyl) -2-methyl-1h-pyrrol-3-yl]methyl} -4- methylpiperazine, synthesis process and uses thereof |
12/19/2007 | EP1865982A1 Hydrogel composition for modulation of topical inflammatory response |
12/19/2007 | EP1865968A2 Topical formulations of borinic acid antibodies and their methods of use |
12/19/2007 | EP1865967A2 Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
12/19/2007 | EP1865961A1 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment |
12/19/2007 | EP1865960A2 Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
12/19/2007 | EP1865950A1 Compounds useful as modulators of the proteasome activity |
12/19/2007 | EP1865930A1 Multilayered dosing systems |
12/19/2007 | EP1597376B1 Chicken rna polymerase i promoter and the use thereof |
12/19/2007 | EP1556021B1 Pharmaceutical compositions comprising flavonoids and menthol |
12/19/2007 | EP1411921B1 Pharmaceutical compositions containing terbinafine and use thereof |
12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
12/19/2007 | EP1326873A4 Combinatorial libraries of monosaccharides |
12/19/2007 | EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
12/19/2007 | EP1131449B1 Method for identifying inhibitors of ipc synthase |
12/19/2007 | EP1095061B1 Peptides based on the sequence of human lactoferrin and their use |
12/19/2007 | EP1091757B1 Alpha emitting constructs and uses thereof |
12/19/2007 | EP1090033B2 Particles of hcv envelope proteins: use for vaccination |
12/19/2007 | EP1032556B1 Pharmaceutically active compounds and methods of use |
12/19/2007 | EP0772689B1 Retroviral vectors having a reduced recombination rate |
12/19/2007 | EP0519001B2 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
12/19/2007 | CN101090977A Tripeptide and tetrapeptide thioethers |
12/19/2007 | CN101090966A Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
12/19/2007 | CN101090727A Intraoral disintegration type solid preparation containing povidone iodine |
12/19/2007 | CN101090716A Treatment of HCV disorders |